IDEAYA Biosciences (IDYA) Misses Q2 EPS by 9c

IDEAYA Biosciences (NASDAQ: IDYA) reported Q2 EPS of ($0.88), $0.09 worse than the analyst estimate of ($0.79).

For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.

You May Also Be Interested In

• Jaguar Health (JAGX) Tops Q2 EPS by 3647c
• Bill.com (BILL) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 Guidance
• JPMorgan Reiterates Overweight Rating on Marvell (MRVL)